Form 4: Atlassian Co-CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, sold shares of Class A Common Stock on May 10, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on May 10, 2024.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on February 21, 2023.
- A total of 8,241 shares were sold at prices ranging from $178.89 to $182.86.
- The sales were conducted in multiple trades throughout the day, with weighted-average prices reported for each set of transactions.
- Following the reported transactions, Cannon-Brookes indirectly owns 267,558 to 274,712 shares through a trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports stock sales under a pre-arranged plan, which is a normal course of business. There is no indication of positive or negative implications.
Positives
- The sales were conducted under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Industry Context
Sales by insiders are common and are usually not a cause for concern unless there are other red flags. Rule 10b5-1 plans are designed to allow insiders to sell shares without being accused of insider trading.
Key Dates
| Date | Description |
|---|---|
| February 21, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| May 10, 2024 | Date of the stock sale transactions |
| May 13, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.